# The Human Medicines Regulations 2012, Paragraph 14F


An MM master file must contain, as a minimum, the following information—
(a) the information specified in paragraph 1A(2) of Schedule 3; and
(b) the location and identification of any modular unit at which manufacturing or assembly of the MM medicinal product has commenced, has been suspended or has ceased, the date on which manufacturing or assembly commenced or ceased, and the dates on which it was suspended.

---
Source: https://www.legislation.gov.uk/uksi/2012/1916/schedule/4/paragraph/14F (the official version)
Page: https://openlegislation.uk/human-medicines-regulations-2012/schedule-4/paragraph-14F
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.